PIK3CB and cancer: Dysregulation of phosphoinositide kinases, primarily in class IA PI3K, have been discovered in a number of human diseases, with mutations leading to either increased or decreased enzymatic activity being critically involved in cancer [9], developmental disorders [10], and primary immune deficiencies [11,12,13].